Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Thrombocytopenia 6Neoplasms 1Lymphoma 1Liver Diseases 1Jacobs syndrome 1Gastrointestinal Neoplasms 1Chemotherapy-induced Thrombocytopenia 1Carcinoma, Hepatocellular 1

Interventions

Sorafenib 5lenvatinib 2ledipasvir, sofosbuvir drug combination 2halofantrine 2atezolizumab 2Liver Transplantation 2Immunotherapy 2Control Groups 2Blood Specimen Collection 2Bevacizumab 2Antibodies 2veliparib 1trifluridine tipiracil drug combination 1trametinib 1titanium silicide 1sintilimab 1rubitecan 1repotrectinib 1pevonedistat 1pembrolizumab 1ozanimod 1linifanib 1genexol-PM 1fluorocholine 1fisogatinib 1ficlatuzumab 1durvalumab 1camrelizumab 1belinostat 1bavituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Liver Diseases × avatrombopag × Clear all
NCT04437953 2020-12-08

Avatrombopag for Thrombocytopenia in People With Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Withdrawn
Classical hematology

Liver Diseases, Neoplasms, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡